Rigid Endoscope Global Market Report 2024

The rigid endoscope market has grown strongly in recent years. It will grow from $4.6 billion in 2023 to $5.01 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The expansion observed in the historical period can be linked to several factors, including global civil unrest, urbanization, and population density. Additionally, political instability, the potential for public disorder at large events, and efforts in military and law enforcement modernization have contributed to this growth.

The rigid endoscope market is expected to see strong growth in the next few years. It will grow to $6.76 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The anticipated growth in the forecast period is driven by factors such as terrorism and asymmetric threats, unrest related to pandemics, concerns surrounding public events and mass gatherings, national security considerations, and increased public awareness and advocacy. Noteworthy trends in the forecast period encompass the adoption of non-lethal technologies, integrated communication systems, advanced riot control vehicles, crowd monitoring and analysis solutions, less-lethal projectiles and ammunition, as well as the utilization of training simulators and virtual reality for enhanced preparedness.

The anticipated growth in the rigid endoscope market is fueled by the increasing prevalence of cancer and gastrointestinal disorders. Cancer, characterized by abnormal cell growth leading to organ and tissue dysfunction, and gastrointestinal disorders affecting the digestive system, are driving the demand for rigid endoscopes. These instruments play a crucial role in diagnosing and treating these conditions, enabling clinicians to visualize the internal body, perform biopsies, and conduct minimally invasive operations for earlier diagnosis and effective treatment. In January 2023, the American Cancer Society reported a 3.16% increase in cancer cases from 2021 to 2023, highlighting the significance of early detection. Additionally, the International Agency for Research on Cancer noted that gastrointestinal cancers account for a significant portion of global cancer cases and deaths, emphasizing the role of rigid endoscopes in addressing such conditions.

The contributing to the growth of the rigid endoscope market is the rising aging population. The demographic trend of an increasing proportion of elderly individuals is driving the utilization of rigid endoscopes for minimally invasive diagnostic and therapeutic procedures in this demographic. According to the World Health Organization, by 2030, one out of every six individuals globally will be 60 years old or older. The population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion during this period, with a projected global population of individuals aged 60 and older reaching 2.1 billion by 2050. This demographic shift is a significant driver for the rigid endoscope market as the aging population increasingly requires medical interventions and diagnostic procedures facilitated by these instruments.

A prominent trend in the rigid endoscope market is the emphasis on product innovations, with major players dedicating efforts to develop cutting-edge products to enhance their market positioning. An example of this trend is Integrated Endoscopy, a US-based medical device company, which introduced the Gen II NUVIS in November 2022. This single-use rigid endoscope, designed for arthroscopic surgical procedures, features 4K resolution and operates on a battery, eliminating the need for cords. The Gen II NUVIS incorporates a patent-pending streamlined optical train design, reducing the number of optical elements by over 60%, resulting in improved image quality and cost-effective production. The device also includes a built-in battery-powered LED, replacing traditional lightboxes and heavy light cords.

Major companies in the rigid endoscope market are actively engaged in the development of groundbreaking endoscopic devices, such as wireless endoscopic cameras, to enhance their market share and profitability. Wireless endoscopic cameras utilize wireless technology to transmit high-definition visuals from an endoscope directly to a display or monitor. In March 2022, Endoluxe, a US-based developer of portable endoscopic visualization and media storage platforms, introduced TowerTech, a high-definition wireless endoscopic camera suitable for various endoscopic procedures. This innovation eliminates the need for traditional endoscopic towers, offering a handheld Orb for use with standard rigid and flexible analog scopes. TowerTech integrates all necessary visualization features into the camera head, streamlining the endoscopic platform.

In November 2021, Healthcare Components Group, a UK-based manufacturer and supplier of mission-critical components and solutions for the healthcare industry, acquired Endoscopy Development Company (EDC), a US-based manufacturer of flexible and rigid endoscopy replacement parts. This strategic acquisition aims to enhance Healthcare Components Group's offerings in components used for developing and repairing endoscopes, providing customers with improved solutions. The acquisition also offers employees of Endoscopy Development Company (EDC) opportunities for career growth within the expanded and robust endoscopy business of Healthcare Components Group.

Major companies operating in the rigid endoscope market report are Stryker Corporation, Karl Storz SE & Co. KG, Richard Wolf GmbH, Olympus Corporation, Medtronic plc, CONMED Corporation, Smith & Nephew plc, B Braun Melsungen AG, Henke-Sass Wolf GmbH, Ethicon Inc., Fujifilm Holdings Corporation, Integrated Endoscopy Inc., NeoScope Inc., PENTAX Medical, Optomic España SA, 3A Composites, Hoya Corporation, Aesculap Inc., Boston Scientific Corporation, Cook Medical Inc., Pristine Surgical LLC, Allengers Medical Systems Ltd., Aspen Surgical Products Inc., Bausch Health Companies Inc., Beacon Medical Group, Cardinal Health Inc., GI Dynamics Inc., Catalyst Medical Solutions Ltd., HealthTrust, EndoChoice Holdings Inc.

North America was the largest region in the rigid endoscope market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global rigid endoscope market during the forecast period. The regions covered in the rigid endoscope market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rigid endoscope market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main categories of rigid endoscopes include laparoscopes, arthroscopies, gynecological endoscopes, ENT endoscopy, urology endoscopy, neurology endoscopy, and others. Specifically, a laparoscope is a compact tube equipped with a light source and camera that transmits images of the abdomen or pelvis to a television monitor. This technology is essential for laparoscopy, a surgical technique that allows surgeons to visualize the interior of the abdomen and pelvis without extensive skin incisions. The benefits of laparoscopy include reduced hospitalization duration, faster recovery times, decreased post-surgery discomfort and bleeding, and minimized scarring. Hygiene practices related to rigid endoscopes include single-use, reprocessing, and sterilization procedures. These protocols are meticulously implemented in various healthcare settings, including hospitals, clinics, ambulatory surgical centers (ASC), and others.

The rigid endoscopes market research report provides rigid endoscopes market statistics, including rigid endoscopes industry global market size, regional shares, competitors with a rigid endoscopes market share, detailed rigid endoscopes market segments, market trends and opportunities, and any further data you may need to thrive in the rigid endoscopes industry. This rigid endoscopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rigid endoscope market consists of sales of straight rod non-separable tube endoscope, straight rod separable tube endoscope, curved tube non-separable tube endoscope and curved tube separable tube endoscope. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.